Literature DB >> 22474290

Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation.

Xiaohai Wang1, Wen-Jye Lin, Kouji Izumi, Qi Jiang, Kuo-Pao Lai, Defeng Xu, Lei-Ya Fang, Tianjing Lu, Lei Li, Shujie Xia, Chawnshang Chang.   

Abstract

Infiltrated macrophages may play important roles in the development and progression of benign prostatic hyperplasia (BPH), but the underlying mechanisms remain largely unknown. We found increased macrophages infiltration in human and mouse BPH tissues. By establishing a co-culture transwell system, we found increased migration of macrophages and proliferation of prostate stromal cells during co-culture. Importantly, stromal androgen receptor (AR) could enhance the migration of macrophages and macrophage-mediated stromal cell proliferation. We identified CCL3 as an AR downstream player, and found CCL3 levels were notably increased in human and mouse BPH prostates. Ablation of prostate stromal AR in a mouse BPH model significantly reduced CCL3 expression levels in prostates. Consistently, targeting AR via an AR degradation enhancer, ASC-J9®, or neutralization of CCL3 with an antibody, resulted in suppression of macrophage migration and prostate stromal cell growth. Our study provides mechanistic insights on the regulation of prostate stromal cells by macrophages via stromal AR/CCL3 signaling pathways, which could potentially allow the development of therapeutic approaches for battling BPH with persistent inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474290      PMCID: PMC3365773          DOI: 10.1074/jbc.M112.355164

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2.

Authors:  Suman M Reddy; K-H Kevin Hsiao; Vivian Elizabeth Abernethy; Hanli Fan; Angelika Longacre; Wilfred Lieberthal; Joyce Rauch; Jason S Koh; Jerrold S Levine
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

2.  Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia.

Authors:  G Bartsch; H R Müller; M Oberholzer; H P Rohr
Journal:  J Urol       Date:  1979-10       Impact factor: 7.450

3.  Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.

Authors:  Gero Kramer; Georg E Steiner; Alessandra Handisurya; Ursula Stix; Andrea Haitel; Birgit Knerer; Alois Gessl; Chung Lee; Michael Marberger
Journal:  Prostate       Date:  2002-06-01       Impact factor: 4.104

Review 4.  Role of estrogens in human benign prostatic hyperplasia.

Authors:  F Sciarra; V Toscano
Journal:  Arch Androl       Date:  2000 May-Jun

5.  Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.

Authors:  Georg E Steiner; Martin E Newman; Doris Paikl; Ursula Stix; Nima Memaran-Dagda; Chung Lee; Michael J Marberger
Journal:  Prostate       Date:  2003-08-01       Impact factor: 4.104

6.  Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate.

Authors:  Karin Dillner; Jon Kindblom; Amilcar Flores-Morales; Ruijin Shao; Jan Törnell; Gunnar Norstedt; Håkan Wennbo
Journal:  Endocrinology       Date:  2003-08-07       Impact factor: 4.736

7.  Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.

Authors:  Jon Kindblom; Karin Dillner; Lena Sahlin; Fiona Robertson; Christopher Ormandy; Jan Törnell; Håkan Wennbo
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

Review 8.  Inflammation and chronic prostatic diseases: evidence for a link?

Authors:  Alessandro Sciarra; Franco Di Silverio; Stefano Salciccia; Ana Maria Autran Gomez; Alessandro Gentilucci; Vincenzo Gentile
Journal:  Eur Urol       Date:  2007-07-02       Impact factor: 20.096

9.  Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue.

Authors:  Georg E Steiner; Ursula Stix; Alessandra Handisurya; Martin Willheim; Andrea Haitel; Franz Reithmayr; Doris Paikl; Rupert C Ecker; Kristian Hrachowitz; Gero Kramer; Chung Lee; Michael Marberger
Journal:  Lab Invest       Date:  2003-08       Impact factor: 5.662

10.  Isolation and culture of murine macrophages.

Authors:  John Q Davies; Siamon Gordon
Journal:  Methods Mol Biol       Date:  2005
View more
  35 in total

Review 1.  Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.

Authors:  Simeng Wen; Hong-Chiang Chang; Jing Tian; Zhiqun Shang; Yuanjie Niu; Chawnshang Chang
Journal:  Am J Pathol       Date:  2014-11-26       Impact factor: 4.307

2.  Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.

Authors:  Petra Popovics; Andrew V Schally; Luis Salgueiro; Krisztina Kovacs; Ferenc G Rick
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-25       Impact factor: 11.205

3.  Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse.

Authors:  LaTayia M Aaron-Brooks; Takeshi Sasaki; Renee E Vickman; Lin Wei; Omar E Franco; Yuan Ji; Susan E Crawford; Simon W Hayward
Journal:  Prostate       Date:  2019-04-18       Impact factor: 4.104

Review 4.  Personalized medicine for the management of benign prostatic hyperplasia.

Authors:  Seth K Bechis; Alexander G Otsetov; Rongbin Ge; Aria F Olumi
Journal:  J Urol       Date:  2014-02-25       Impact factor: 7.450

5.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01

6.  Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

Authors:  Ferenc G Rick; Andrew Abi-Chaker; Luca Szalontay; Roberto Perez; Miklos Jaszberenyi; Arumugam R Jayakumar; Nagarajarao Shamaladevi; Karoly Szepeshazi; Irving Vidaurre; Gabor Halmos; Awtar Krishan; Norman L Block; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

7.  Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis.

Authors:  Fabiana N Soki; Amy J Koh; Jacqueline D Jones; Yeo Won Kim; Jinlu Dai; Evan T Keller; Kenneth J Pienta; Kamran Atabai; Hernan Roca; Laurie K McCauley
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

Review 8.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors:  Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal:  Nat Rev Urol       Date:  2016-09-30       Impact factor: 14.432

9.  Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).

Authors:  Kuo-Pao Lai; Chiung-Kuei Huang; Lei-Ya Fang; Kouji Izumi; Chi-Wen Lo; Ronald Wood; Jon Kindblom; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2013-07-26

Review 10.  Macrophages and cellular immunity in Drosophila melanogaster.

Authors:  Katrina S Gold; Katja Brückner
Journal:  Semin Immunol       Date:  2016-04-23       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.